TrialOncology2018

An Intergroup Randomized Phase II Study of Bevacizumab or Cetuximab in Combination with Gemcitabine and in Combination with Chemoradiation in Patients with Resected Pancreatic Carcinoma: A Trial of the ECOG-ACRIN Cancer Research Group (E2204).

Jordan D Berlin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.